"MSCs have the unique ability to become chondrocytes cells that build and maintain healthy cartilage," explained Dr Tulpule.

Total Revenue Growth of 27% to $57.9 MillionGross Margin of 72% and Adjusted EBITDA Growth of 84%Full-Year Profitability Guidance RaisedFDA ...

This not only limits MSC function but also hampers its ability to modulate the immune environment and differentiate into chondrocytes, the cells responsible for cartilage formation. This can lead ...

Return on Equity (ROE): Vericel's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -1.96%, the company showcases efficient use of ...

Leerink Partnrs lifted their FY2024 earnings per share (EPS) estimates for Vericel in a research note issued to investors on Thursday, November 7th. Leerink Partnrs analyst M. Kratky now forecasts ...

Researchers conducted a study to determine if variations in the MTNR1A gene, specifically the MRNR1A variant (rs374152717), could be a genetic cause of idiopathic osteoporosis.

The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple ...

Skeletal stem cells have been isolated from various tissues, including periosteum and bone marrow, where they exhibit key functions in bone biology and hematopoiesis, respectively. The role of ...

Several lines of evidence both from experimental models and from clinical studies reveal that TNF-like ligand 1A (TL1A) and its interaction with death receptor 3 (DR3) is critically involved in ...

-- Vericel a annoncé jeudi une perte nette de 0,02 $ par action diluée pour le troisième trimestre, en baisse par rapport à ...